Distressed acquisition below last-round valuation · Fatal mistake: Alleged programme to embed pharmaceutical-sponsored clinical decision support alerts in EHR workflows effectively turned physician clinical decisions into a covert opioid marketing channel, resulting in $145M federal penalty.
Evaluating only Practice Fusion’s profile at its peak — without knowing the outcome — the model ranked Unit economics as the #1 likely cause. Documented cause: Fraud.
Key Events Timeline
FOUNDING
Practice Fusion founded
FRAUD EXPOSURE
Fraud allegations surface
ACQUISITION ATTEMPT
Fire Sale: Practice Fusion ceases operations
Full Analysis
Free · no account needed
Documented cause
Practice Fusion launched in 2005 as a free, cloud-based electronic health record system for physician practices — an unusual model at a time when EHR software typically cost tens of thousands of dollars. By offering a free EHR, the company rapidly acquired a large installed base of physician users. At its peak, Practice Fusion had over 30,000 medical practices and 5 million patient records on its platform. The company raised $157 million and was valued at $1.5 billion at its peak. In 2018, Allscripts acquired Practice Fusion for $100 million — a sharp markdown from that peak valuation. The real shock came in 2020 when Practice Fusion agreed to pay $145 million to resolve criminal and civil charges brought by the US Department of Justice. The core allegation was that Practice Fusion had solicited and received millions of dollars from pharmaceutical companies — most prominently Purdue Pharma, the maker of OxyContin — to insert "clinical decision support" alerts into its EHR that prompted physicians to prescribe extended-release opioids when viewing certain patient records. The programme was allegedly designed to look like neutral clinical guidance while actually functioning as a covert marketing channel for opioid manufacturers during the height of the opioid epidemic.
Lesson
“If your free product is paid for by third parties whose interests may conflict with your users' professional responsibilities, disclose it completely — or you will eventually face the consequences that Practice Fusion faced.”
Failure anatomy
Collapse type
Fire Sale
📉 MEDIUM
Hype cycle
trough of disillusionment
Moat type
Switching Costs
Fatal mistake
Alleged programme to embed pharmaceutical-sponsored clinical decision support alerts in EHR workflows effectively turned physician clinical decisions into a covert opioid marketing channel, resulting in $145M federal penalty.
FAQ
What exactly did Practice Fusion allegedly do?
According to the DOJ, Practice Fusion solicited millions of dollars from Purdue Pharma and other pharmaceutical companies to create "clinical decision support" alerts that appeared to offer neutral medical guidance but were actually designed to prompt physicians to prescribe extended-release opioids to specific patient populations. The alerts were embedded in the EHR interface at key prescription decision points.
What happened to Practice Fusion after the Allscripts acquisition?
Allscripts acquired Practice Fusion in 2018 for $100M. The DOJ charges were resolved in 2020 with a $145M settlement. Allscripts continued to operate the Practice Fusion product as part of its EHR portfolio, though the brand was tainted by the federal proceedings.
Did any physicians know their clinical alerts were pharma-sponsored?
The DOJ alleged that the sponsorship was not clearly disclosed to physicians in ways that would allow them to evaluate the alerts as advertising rather than clinical guidance. This non-disclosure was central to the fraud allegations — physicians making prescribing decisions believed they were acting on neutral clinical recommendations.